Purification and characterization of a tumor lipid-mobilizing factor.
about
Role of beta3-adrenergic receptors in the action of a tumour lipid mobilizing factorCigarette smoking induces overexpression of a fat-depleting gene AZGP1 in the humanModulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF)Inhibition of preadipocyte differentiation and adipogenesis by zinc-α2-glycoprotein treatment in 3T3-L1 cellsDownregulation of zinc-{alpha}2-glycoprotein in adipose tissue and liver of obese ob/ob mice and by tumour necrosis factor-alpha in adipocytes.Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia.Perturbations in the lipid profile of individuals with newly diagnosed type 1 diabetes mellitus: lipidomics analysis of a Diabetes Antibody Standardization Program sample subsetEnhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patientsCancer cachexia: mechanisms and clinical implications.Pancreatic cancer cachexia: a review of mechanisms and therapeutics.Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus.Improved adipose tissue metabolism after 5-year growth hormone replacement therapy in growth hormone deficient adults: The role of zinc-α2-glycoprotein.Zinc-alpha 2-glycoprotein gene expression in adipose tissue is related with insulin resistance and lipolytic genes in morbidly obese patients.The Newest Hypothesis about Vitiligo: Most of the Suggested Pathogeneses of Vitiligo Can Be Attributed to Lack of One Factor, Zinc-α2-GlycoproteinAdipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing miceThe role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexiaEffect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor.Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factorApplication of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset.Thyroid hormone upregulates zinc-α2-glycoprotein production in the liver but not in adipose tissue.White adipose tissue overproduces the lipid-mobilizing factor zinc α2-glycoprotein in chronic kidney disease.The role of triglyceride lipases in cancer associated cachexia.Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo.Role of lipid-mobilising factor (LMF) in protecting tumour cells from oxidative damage.Pas de deux: natural killer receptors and MHC class I ligands in primates.Effects of activation of AMPK on human breast cancer cell lines with different genetic backgrounds.Changes in zinc-α2-glycoprotein (ZAG) plasma concentrations pre and post Roux-En-Y gastric bypass surgery (RYGB) or a very low calorie (VLCD) diet in clinically severe obese patients: Preliminary Study.Zinc-α2-Glycoprotein Is Associated with Obesity in Chinese People and HFD-Induced Obese Mice.The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells.
P2860
Q24643312-CCD924E2-A29C-46D2-B206-891CA7A37068Q24648354-09F0CBAD-3808-48DF-8B84-92A21396C2D2Q28348284-E7623B4C-3E70-4E3D-9F86-ECDC3DB9ED59Q33588867-DA9B44C8-7401-40CE-A85F-9CABFFBC053BQ33594159-7E981084-7F3C-4BF0-9999-A0A32B8F131DQ33976184-5B116611-27E5-4342-8EF6-A9C438BEFC88Q34056584-0C0B1AF3-E2C2-4C17-82AA-5136356DE849Q34627823-1766B5D1-8285-4224-8260-1CBADD8D9F77Q34631019-7DAFEFDE-4C10-4BA5-B188-BDBC601C5338Q34660312-DE604F13-629A-4EFE-8EA3-B3DC2076A6A5Q35054991-D2154706-1F81-443E-8F94-659ABB730441Q35834766-FDEC8899-0489-4399-9999-113E7DEBCC35Q35839862-067F6685-6540-4A59-8E7B-AB9E2C7C36C6Q36072254-2F763736-0707-4D57-A1C5-28E16F93F386Q36612337-800A79D2-8B23-4C87-92FC-1B7B5514FFA9Q36616360-29150ECF-8D41-4E6B-A314-F12F85707EDEQ36641780-ACEC568A-73EC-4993-802E-C87292D231F5Q36644080-4415C671-18C0-46D4-A62A-0684E7945370Q37168731-1C5FF8B9-0F26-4D79-B2AF-980B29B2C72DQ37499691-BA5E30AD-E856-43DD-8F1B-1ADDD10425B9Q37609992-EF4B798D-3E8D-487A-9449-A8C15B51CAF7Q38090208-8972294F-E514-43AA-83A1-B2E300C6820AQ38289950-E7FB1D74-250A-46EF-860F-54645B8BEB47Q38797493-F1457E47-B59D-400F-9FD5-BFA822B93112Q40614356-AFA37381-9D83-4108-9836-2DF0FB2ECD45Q42107110-7EBC36C6-2C76-4479-9612-E0BDAA27201DQ49723188-1358219D-D825-4CE9-A7FA-AF73DBCFEBDAQ50244794-FB3587D1-FF07-4833-9C89-566E0D2F9D04Q55455921-F427F542-045E-4D8A-8437-11AE95E05772
P2860
Purification and characterization of a tumor lipid-mobilizing factor.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Purification and characterization of a tumor lipid-mobilizing factor.
@ast
Purification and characterization of a tumor lipid-mobilizing factor.
@en
Purification and characterization of a tumor lipid-mobilizing factor.
@nl
type
label
Purification and characterization of a tumor lipid-mobilizing factor.
@ast
Purification and characterization of a tumor lipid-mobilizing factor.
@en
Purification and characterization of a tumor lipid-mobilizing factor.
@nl
prefLabel
Purification and characterization of a tumor lipid-mobilizing factor.
@ast
Purification and characterization of a tumor lipid-mobilizing factor.
@en
Purification and characterization of a tumor lipid-mobilizing factor.
@nl
P2093
P1433
P1476
Purification and characterization of a tumor lipid-mobilizing factor
@en
P2093
P304
P407
P577
1998-06-01T00:00:00Z